SPY305.55+1.23 0.40%
DIA255.27+0.98 0.39%
IXIC9,552.05+62.18 0.66%

Wells Fargo Maintains Equal-Weight on Infinity Pharmaceuticals, Lowers Price Target to $1

Wells Fargo maintains Infinity Pharmaceuticals (NASDAQ:INFI) with a Equal-Weight and lowers the price target from $1.5 to $1.

Benzinga · 05/12/2020 12:25

Wells Fargo maintains Infinity Pharmaceuticals (NASDAQ:INFI) with a Equal-Weight and lowers the price target from $1.5 to $1.